KYMR
Kymera Therapeutics, Inc.$113.39+1.38 (+1.23%)Prev Close$112.08·MCap$9.82B·P/E—·Vol263.4K·Yield—
▲
Buys (12M)
1
$172.50M
▼
Sells (12M)
40
$470.52M
◆
Net Activity
Net Seller
$298.02M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Kymera Therapeutics, Inc. (KYMR) has been dominated by selling, with 1 insider purchase totaling $172.50M and 40 insider sales totaling $470.52M. The most recent insider transaction was by Mainolfi Nello (director, officer: Chief Executive Officer), who sold $5.95M worth of shares on Jul 7, 2026. Kymera Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $9.82B.
KYMR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 50,000 | $119.00 | $5.95M | 666,568 |
| Jul 2, 2026 | Jacobs Bruce N. | officer: Chief Financial Officer | Sell | 77,109 | $114.96 | $8.86M | 320,492 |
| Jul 2, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 3,389 | $114.29 | $387.3K | 47,179 |
| Jul 2, 2026 | Booth Bruce | director | Sell | 76,650 | $108.05 | $8.28M | 2,446,375 |
| Jul 2, 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 80,000 | $115.29 | $9.22M | 744,685 |
| Jun 30, 2026 | Booth Bruce | director | Sell | 544,528 | $109.98 | $59.88M0.7% OS | 2,834,055 |
| Jun 26, 2026 | BVF PARTNERS L P/IL | director, other: See Remarks and Footnotes | Sell | 1,630,658 | $106.50 | $173.66M2.0% OS | 1,960,881-45% |
| Jun 25, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 2,500 | $119.00 | $297.5K | 50,195 |
| Jun 25, 2026 | Booth Bruce | director | Sell | 684,449 | $115.13 | $78.80M0.8% OS | 3,461,521 |
| Jun 22, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 2,500 | $99.00 | $247.5K | 50,195 |
| Jun 22, 2026 | Booth Bruce | director | Sell | 509,996 | $95.28 | $48.59M0.6% OS | 3,807,660 |
| May 27, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 17,184 | $79.92 | $1.37M | 57,472 |
| May 11, 2026 | Ridloff Elena | director | Sell | 3,000 | $87.00 | $261.0K | 0Exit |
| Apr 29, 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 30,000 | $81.18 | $2.44M | 679,190 |
| Apr 24, 2026 | Booth Bruce | director | Sell | 6,000 | $89.96 | $539.8K | 3,899,829 |
| Apr 24, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 300 | $90.00 | $27.0K | 61,202 |
| Apr 16, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 6,551 | $90.00 | $589.6K | 61,202 |
| Apr 16, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 1,347 | $90.00 | $121.2K | 50,195 |
| Apr 16, 2026 | Booth Bruce | director | Sell | 9,494 | $90.01 | $854.5K | 3,899,917 |
| Apr 10, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 10,264 | $87.47 | $897.8K | 58,712 |
| Apr 1, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 22,240 | $85.43 | $1.90M | 62,302-26% |
| Apr 1, 2026 | Ridloff Elena | director | Sell | 12,000 | $85.39 | $1.02M | 1,200-91% |
| Mar 25, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 115,977 | $78.02 | $9.05M | 129,696-47% |
| Mar 20, 2026 | Esposito Pamela | director | Sell | 2,500 | $79.15 | $197.9K | 1,800-58% |
| Mar 11, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 25,758 | $83.30 | $2.15M | 92,045 |
| Feb 25, 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 30,000 | $90.26 | $2.71M | 676,431 |
| Feb 20, 2026 | Esposito Pamela | Director | Sell | 4,400 | $87.20 | $383.7K | 600-88% |
| Jan 20, 2026 | Esposito Pamela | director | Sell | 5,500 | $67.91 | $373.5K | 5,100-52% |
| Dec 31, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $78.06 | $2.34M | 669,091 |
| Dec 17, 2025 | Esposito Pamela | Sell | 27,563 | $82.16 | $2.26M | 13,058-68% | |
| Dec 12, 2025 | Booth Bruce | Sell | 236,588 | $91.72 | $21.70M | 4,141,757 | |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | Buy | 2,005,813 | $86.00 | $172.50M2.5% OS | 7,955,916+34% | |
| Dec 8, 2025 | Albers Jeffrey W. | Sell | 5,000 | $89.76 | $448.8K | 2,252-69% | |
| Dec 8, 2025 | Gollob Jared | Chief Medical Officer | Sell | 49,307 | $88.67 | $4.37M | 145,540-25% |
| Dec 8, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 100,000 | $89.17 | $8.92M | 660,482 |
| Oct 29, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $60.99 | $1.83M | 688,620 |
| Oct 15, 2025 | Gollob Jared | Chief Medical Officer | Sell | 59,576 | $61.42 | $3.66M | 140,304-30% |
| Oct 14, 2025 | Albers Jeffrey W. | Sell | 5,000 | $59.19 | $295.9K | 0Exit | |
| Oct 14, 2025 | Gollob Jared | Chief Medical Officer | Sell | 3,114 | $60.00 | $186.8K | 118,359 |
| Sep 17, 2025 | Jacobs Bruce N. | Chief Financial Officer | Sell | 79,220 | $50.00 | $3.96M | 227,409-26% |
| Sep 16, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $49.00 | $1.47M | 660,482 |
| Jul 1, 2025 | BVF PARTNERS L P/IL | Director | Buy | 317,167 | $44.00 | $13.96M | 2,798,795 |
| Jun 30, 2025 | BAKER BROS. ADVISORS LP | Buy | 655,500 | $44.00 | $28.84M0.8% OS | 6,117,295 | |
| Jun 11, 2025 | Ridloff Elena | Sell | 4,500 | $50.00 | $225.0K | 0Exit | |
| Jun 3, 2025 | Albers Jeffrey W. | Sell | 6,349 | $49.00 | $311.1K | 0Exit | |
| Jun 3, 2025 | Esposito Pamela | Sell | 5,000 | $49.04 | $245.2K | 0Exit | |
| Jun 3, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $49.00 | $1.47M | 660,482 |
| Jun 3, 2025 | Ridloff Elena | Sell | 12,000 | $46.10 | $553.2K | 4,800-71% | |
| May 23, 2025 | Chadwick Jeremy G | Chief Operating Officer | Sell | 2,575 | $29.30 | $75.4K | 66,420 |
| Mar 3, 2025 | Chadwick Jeremy G | Chief Operating Officer | Sell | 1,383 | $30.45 | $42.1K | 68,052 |
Showing 1–50 of 115
1 / 3
KYMR Insider Buying Activity
The following table shows recent insider purchases of Kymera Therapeutics, Inc. (KYMR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | Buy | 2,005,813 | $86.00 | $172.50M2.5% OS | 7,955,916+34% | |
| Jul 1, 2025 | BVF PARTNERS L P/IL | Director | Buy | 317,167 | $44.00 | $13.96M | 2,798,795 |
| Jun 30, 2025 | BAKER BROS. ADVISORS LP | Buy | 655,500 | $44.00 | $28.84M0.8% OS | 6,117,295 |
KYMR Insider Selling Activity
The following table shows recent insider sales of Kymera Therapeutics, Inc. (KYMR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 50,000 | $119.00 | $5.95M | 666,568 |
| Jul 2, 2026 | Jacobs Bruce N. | officer: Chief Financial Officer | Sell | 77,109 | $114.96 | $8.86M | 320,492 |
| Jul 2, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 3,389 | $114.29 | $387.3K | 47,179 |
| Jul 2, 2026 | Booth Bruce | director | Sell | 76,650 | $108.05 | $8.28M | 2,446,375 |
| Jul 2, 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 80,000 | $115.29 | $9.22M | 744,685 |
| Jun 30, 2026 | Booth Bruce | director | Sell | 544,528 | $109.98 | $59.88M0.7% OS | 2,834,055 |
| Jun 26, 2026 | BVF PARTNERS L P/IL | director, other: See Remarks and Footnotes | Sell | 1,630,658 | $106.50 | $173.66M2.0% OS | 1,960,881-45% |
| Jun 25, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 2,500 | $119.00 | $297.5K | 50,195 |
| Jun 25, 2026 | Booth Bruce | director | Sell | 684,449 | $115.13 | $78.80M0.8% OS | 3,461,521 |
| Jun 22, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 2,500 | $99.00 | $247.5K | 50,195 |
| Jun 22, 2026 | Booth Bruce | director | Sell | 509,996 | $95.28 | $48.59M0.6% OS | 3,807,660 |
| May 27, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 17,184 | $79.92 | $1.37M | 57,472 |
| May 11, 2026 | Ridloff Elena | director | Sell | 3,000 | $87.00 | $261.0K | 0Exit |
| Apr 29, 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 30,000 | $81.18 | $2.44M | 679,190 |
| Apr 24, 2026 | Booth Bruce | director | Sell | 6,000 | $89.96 | $539.8K | 3,899,829 |
| Apr 24, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 300 | $90.00 | $27.0K | 61,202 |
| Apr 16, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 6,551 | $90.00 | $589.6K | 61,202 |
| Apr 16, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 1,347 | $90.00 | $121.2K | 50,195 |
| Apr 16, 2026 | Booth Bruce | director | Sell | 9,494 | $90.01 | $854.5K | 3,899,917 |
| Apr 10, 2026 | Goodman Noah | officer: Chief Business Officer | Sell | 10,264 | $87.47 | $897.8K | 58,712 |
| Apr 1, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 22,240 | $85.43 | $1.90M | 62,302-26% |
| Apr 1, 2026 | Ridloff Elena | director | Sell | 12,000 | $85.39 | $1.02M | 1,200-91% |
| Mar 25, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 115,977 | $78.02 | $9.05M | 129,696-47% |
| Mar 20, 2026 | Esposito Pamela | director | Sell | 2,500 | $79.15 | $197.9K | 1,800-58% |
| Mar 11, 2026 | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 25,758 | $83.30 | $2.15M | 92,045 |
| Feb 25, 2026 | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 30,000 | $90.26 | $2.71M | 676,431 |
| Feb 20, 2026 | Esposito Pamela | Director | Sell | 4,400 | $87.20 | $383.7K | 600-88% |
| Jan 20, 2026 | Esposito Pamela | director | Sell | 5,500 | $67.91 | $373.5K | 5,100-52% |
| Dec 31, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $78.06 | $2.34M | 669,091 |
| Dec 17, 2025 | Esposito Pamela | Sell | 27,563 | $82.16 | $2.26M | 13,058-68% | |
| Dec 12, 2025 | Booth Bruce | Sell | 236,588 | $91.72 | $21.70M | 4,141,757 | |
| Dec 8, 2025 | Albers Jeffrey W. | Sell | 5,000 | $89.76 | $448.8K | 2,252-69% | |
| Dec 8, 2025 | Gollob Jared | Chief Medical Officer | Sell | 49,307 | $88.67 | $4.37M | 145,540-25% |
| Dec 8, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 100,000 | $89.17 | $8.92M | 660,482 |
| Oct 29, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $60.99 | $1.83M | 688,620 |
| Oct 15, 2025 | Gollob Jared | Chief Medical Officer | Sell | 59,576 | $61.42 | $3.66M | 140,304-30% |
| Oct 14, 2025 | Albers Jeffrey W. | Sell | 5,000 | $59.19 | $295.9K | 0Exit | |
| Oct 14, 2025 | Gollob Jared | Chief Medical Officer | Sell | 3,114 | $60.00 | $186.8K | 118,359 |
| Sep 17, 2025 | Jacobs Bruce N. | Chief Financial Officer | Sell | 79,220 | $50.00 | $3.96M | 227,409-26% |
| Sep 16, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $49.00 | $1.47M | 660,482 |
| Jun 11, 2025 | Ridloff Elena | Sell | 4,500 | $50.00 | $225.0K | 0Exit | |
| Jun 3, 2025 | Albers Jeffrey W. | Sell | 6,349 | $49.00 | $311.1K | 0Exit | |
| Jun 3, 2025 | Esposito Pamela | Sell | 5,000 | $49.04 | $245.2K | 0Exit | |
| Jun 3, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $49.00 | $1.47M | 660,482 |
| Jun 3, 2025 | Ridloff Elena | Sell | 12,000 | $46.10 | $553.2K | 4,800-71% | |
| May 23, 2025 | Chadwick Jeremy G | Chief Operating Officer | Sell | 2,575 | $29.30 | $75.4K | 66,420 |
| Mar 3, 2025 | Chadwick Jeremy G | Chief Operating Officer | Sell | 1,383 | $30.45 | $42.1K | 68,052 |
KYMR Insiders
BVF PARTNERS L P/IL
director, other: See Remarks and Footnotes
Bought $124.12MSold $173.66M
13 tradesLast: Jun 26, 2026
Similar Stocks to KYMR
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B